Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 17, 1998, Pages 10112-10116

  Seth, Aruna ^a   Ourmanov, Ilnour ^b   Kuroda, Marcelo J ^a   Schmitz, Jörn E ^a   Carroll, Miles W ^b   Wyatt, Linda S ^b   Moss, Bernard ^b   Forman, Meryl A ^c   Hirsch, Vanessa M ^b   Letvin, Norman L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BECKMAN COULTER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POL PROTEIN; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURAL GENE; T LYMPHOCYTE SUBPOPULATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

AIDS VACCINES; ANIMALS; BASE SEQUENCE; DNA PRIMERS; EPITOPES; FUSION PROTEINS, GAG-POL; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNIZATION; MACACA MULATTA; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS;

AIDS VIRUS; ANIMALIA; ANKARA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0032544063     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.17.10112     Document Type: Article

References (29)

1. Letvin, N. L. (1998) Science 280, 1875-1880.
2. Bennink, J. R., Yewdell, J. W., Smith, G. L. & Moller, C. (1984) Nature (London) 311, 578-579.
3. Moss, B. (1996) Proc. Natl. Acad. Sci. USA 93, 11341-11348.
4. Mayr, A., Hochstein-Mintzel, V. & Stickl, H. (1975) Infection 3, 6-14.
5. Mayr, A., Stickl, H., Muller, H. K., Danner, K. & Singer, H. (1978) Zentralbl. Bakteriol., Parasitenkd., Infektionskrankh. Hyg., Abt. 1: Orig., Reihe B: 167, 375-390.
6. Carroll, M. & Moss, B. (1997) Virology 238, 198-211.
7. Sutter, G. & Moss, B. (1992) Proc. Natl. Acad. Sci. USA 89, 10847-10851.
8. Sutler, G., Wyatt, L. S., Foley, P. L., Bennink, J. R. & Moss, B. (1994) Vaccine 12, 1032-1040.
9. Hirsch, V. M., Fuerst, T. R., Sutter, G., Carroll, M. W., Yang, L. C., Goldstein, S., Piatak, M., Jr., Elkins, W. R., Alvord, W. G., Montefiori, D. C., et al. (1996) J. Virol. 70, 3741-3752.
10. Wyatt, L. S., Shors, S. T., Murphy, B. R. & Moss, B. (1996) Vaccine 14, 1451-1458.
11. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. & Davis, M. M. (1996) Science 274, 94-96.
12. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al (1998) Science 279, 2103-2106.
13. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. & Ahmed, R. (1998) Immunity 8, 177-187.
14. Gallimore, A., Glithero, A., Godkin, A., Tissot, A., Althage, A., Pluckthun, A., Elliott, T., Hengartner, H. & Zinkernagel, R. (1998) J. Exp. Med. 187, 1383-1393.
15. Callan, M. F., Tan, L., Annels, N., Ogg, G. S., Wilson, J., O'Callaghan, C. A., McMichael, A. J. & Rickinson, A. B. (1998) J. Exp. Med. 187, 1395-1402.
16. Kuroda, M. J., Schmitz, J. E., Barouch, D. H., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A. & Letvin, N. L. (1998) J. Exp. Med. 187, 1373-1381.
17. Boyson, J. E., Shufflebotham, C., Cadavid, L. F., Urvater, J. A., Knapp, L. A., Hughes, A. L. & Watkins, D. I. (1996) J. Immunol. 156, 4656-4665.
18. Carroll, M. W. & Moss, B. (1995) BioTechniques 19, 352-356.
19. Chakraharti, S., Sisler, J. R. & Moss, B. (1997) BioTechniques 23, 1094-1097.
20. Earl, P. L. & Moss, B. (1991) in Current Protocols in Molecular Biology, eds. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. & Struhl, K. (Greene & Wiley, New York), Vol. 2, pp. 16.17.1-16.17.16.
21. Yamamoto, H., Miller, M. D., Tsubota, H., Watkins, D. I., Mazzara, G. P., Stallard, V., Panicali, D. L., Aldovini, A., Young, R. A. & Letvin, N. L. (1990) J. Immunol. 144, 3385-3391.
22. Miller, M. D., Yamamoto, H., Hughes, A. L., Watkins, D. I. & Letvin, N. L. (1991) J. Immunol. 147, 320-329.
23. Allen, T. M., Sidney, J., del Guercio, M. F., Glickman, R. L., Lensmeyer, G. L., Wiebe, D. A., DeMars, R., Pauza, C. D., Johnson, R. P., Sette, A. & Watkins, D. I. (1998) J. Immunol. 160, 6062-6071.
24. Durbin, A., Wyatt, L. S., Slew, J., Moss, B. & Murphy, B. R. (1998) Vaccine, in press.
25. Carroll, M. W., Overwijk, W. W., Chamberlain, R. S., Rosenberg, S. A., Moss, B. & Restifo, N. P. (1997) Vaccine 15, 387-394.
26. Hanke, T., Blanchard, T. J., Schneider, J., Ogg, G. S., Tan, R., Becker, M., Gilbert, S. C., Hill, A. V., Smith, G. L. & McMichael, A. (1998) J. Gen. Virol. 79, 83-90.
27. Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L. & Hill, A. V. (1998) Nat. Med. 4, 397-402.
28. Antoine, G., Scheiflinger, F., Dorner, F. & Falkner, F. G. (1998) Virology 244, 365-396.
29. Blanchard, T. J., Alcami, A., Andrea, P. & Smith, G. L. (1998) J. Cell. Virol. 79, 1159-1167.